SEO URLwww.firestrike.ai/deals/ventyx-biosciences-inc-lilly-acquisition-2026-1

acquisitionAnnounced · Jan 8, 2026biopharmaceuticalSource · CredibleArticle · Factual

Ventyx Biosciences Inc. · Lilly

Lilly acquires Ventyx Biosciences Inc.

David Najork · Founding Software Engineer

Published Apr 29, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

$1.2B

Target

Ventyx Biosciences Inc.

Acquirer

Lilly

Full Acquisition

Status

Announced

Lilly agreed to acquire Ventyx Biosciences Inc.. Reported deal value: $1.2B. Status: Announced. Sector: biopharmaceutical. Target headquarters context: Location not specified.

This page summarizes publicly available information about the transaction as of 2026-01-08. Figures and status may change as filings and press coverage update.

2 Firms Guide Eli Lilly $1.2B Ventyx Biosciences Acquisition By Al Barbarino January 8, 2026, 4:17 PM EST Eli Lilly and Co. has agreed to acquire Ventyx Biosciences Inc. , a San Diego-based clinical-stage biopharmaceutical company , for about $1.2 billion in cash, with Ropes & Gray LLP and Wilson Sonsini

Deal timeline

Announced

Jan 8, 2026 · law360.com

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in biopharmaceutical with a reported deal value of $1.2B. Figures and status may change as sources update.

Sources: law360.com · Primary article · FireStrike proprietary index